Charles River Labs Intl diskutieren
Charles River Labs Intl
WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
198,30 €
0,53 %
Charles River Laboratories International (NYSE:CRL) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $220.00 price target on the stock, up from $185.00.
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for CRL provided by MarketBeat
Neueste Beiträge
Evercore_Inc_ in Coca-Cola Co. diskutieren